Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-19,025
Closed -$4.28M 91
2021
Q4
$4.28M Buy
19,025
+25
+0.1% +$5.28K 0.63% 56
2021
Q3
$4.04M Buy
19,000
+2,000
+12% +$460K 0.58% 55
2021
Q2
$4.14M Hold
17,000
0.54% 63
2021
Q1
$4.23M Buy
+17,000
New +$4.06M 0.54% 54
2020
Q3
Sell
-12,300
Closed -$2.9M 99
2020
Q2
$2.9M Sell
12,300
-6,200
-34% -$1.41M 0.51% 58
2020
Q1
$3.75M Hold
18,500
0.76% 29
2019
Q4
$4.46M Hold
18,500
0.68% 30
2019
Q3
$3.58M Hold
18,500
0.59% 43
2019
Q2
$3.41M Buy
+18,500
New +$3.31M 0.55% 55

Other funds holding AMGN

Clark Estates Inc's AMGN Position: Q1 2022 in Review

Clark Estates Inc sold out of Amgen (AMGN) in Q1 2022, closing a stake of 19,025 shares — an estimated $4.28M sold.

Clark Estates Inc first reported a position in AMGN in Q2 2019 and held it in 9 quarters. The position peaked at $4.46M in Q4 2019. 2,337 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Clark Estates Inc reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
  • Clark Estates Inc sold 19,025 Amgen shares in Q1 2022, an estimated $4.28M.
  • Clark Estates Inc first reported a position in Amgen in Q2 2019 and held it in 9 quarters.
  • Clark Estates Inc's Amgen position peaked at $4.46M in Q4 2019.
  • 2,337 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Clark Estates Inc's 13F filing for Q1 2022, filed 13 May 2022.